Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11746150 Anti-LRP5/6 antibodies and methods of use

Patent 11746150 was granted and assigned to Surrozen on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Wen-Chen Yeh

Parthasarathy Sampathkumar

Tom Zhiye Yuan

Yang Li

Aaron Ken Sato

Date of Patent

September 5, 2023

Patent Application Number

16954483

Date Filed

December 19, 2018

Patent Citations

US Patent 7982013 Frizzled-binding agents and uses thereof

US Patent 8202966 Human Dickkopf-related protein and nucleic acid molecules and uses therefor

US Patent 8221751 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

US Patent 8343922 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells

US Patent 8461155 Sclerostin and the inhibition of WNT signaling and bone formation

US Patent 8507442 Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8

US Patent 8637506 Compositions and methods for bone formation and remodeling

US Patent 8715941 Antibodies to LRP6

...

Patent Primary Examiner

The present invention provides anti-LRP5/6 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for treating diseases and disorders associated with Wnt pathway signaling.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11746150 Anti-LRP5/6 antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.